335 related articles for article (PubMed ID: 18271701)
1. Persistence of CD133+ cells in human and mouse glioma cell lines: detailed characterization of GL261 glioma cells with cancer stem cell-like properties.
Wu A; Oh S; Wiesner SM; Ericson K; Chen L; Hall WA; Champoux PE; Low WC; Ohlfest JR
Stem Cells Dev; 2008 Feb; 17(1):173-84. PubMed ID: 18271701
[TBL] [Abstract][Full Text] [Related]
2. CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.
Bexell D; Gunnarsson S; Siesjö P; Bengzon J; Darabi A
Int J Cancer; 2009 Jul; 125(1):15-22. PubMed ID: 19291792
[TBL] [Abstract][Full Text] [Related]
3. [Preliminary interpretation on the relationship between the phenotype of CD133+ cells and niche in transplanted human glioma in mice].
Song WC; Fei XF; Dong J
Zhonghua Zhong Liu Za Zhi; 2010 Aug; 32(8):564-9. PubMed ID: 21122405
[TBL] [Abstract][Full Text] [Related]
4. Isolation and characterization of cancer stem like cells in human glioblastoma cell lines.
Qiang L; Yang Y; Ma YJ; Chen FH; Zhang LB; Liu W; Qi Q; Lu N; Tao L; Wang XT; You QD; Guo QL
Cancer Lett; 2009 Jun; 279(1):13-21. PubMed ID: 19232461
[TBL] [Abstract][Full Text] [Related]
5. Flow cytometric characterization of the DAOY medulloblastoma cell line for the cancer stem-like phenotype.
Srivastava VK; Nalbantoglu J
Cytometry A; 2008 Oct; 73(10):940-8. PubMed ID: 18773455
[TBL] [Abstract][Full Text] [Related]
6. [Phenotype of SHG-44 glioma stem cell spheres and pathological characteristics of their xenograft tumors].
Wu TF; Chen JM; Chen SS; Chen GL; Wei YX; Xie XS; Du ZW; Zhou YX
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):726-31. PubMed ID: 24378091
[TBL] [Abstract][Full Text] [Related]
7. Glial progenitor-like phenotype in low-grade glioma and enhanced CD133-expression and neuronal lineage differentiation potential in high-grade glioma.
Rebetz J; Tian D; Persson A; Widegren B; Salford LG; Englund E; Gisselsson D; Fan X
PLoS One; 2008 Apr; 3(4):e1936. PubMed ID: 18398462
[TBL] [Abstract][Full Text] [Related]
8. Implantation of GL261 neurospheres into C57/BL6 mice: a more reliable syngeneic graft model for research on glioma-initiating cells.
Yi L; Zhou C; Wang B; Chen T; Xu M; Xu L; Feng H
Int J Oncol; 2013 Aug; 43(2):477-84. PubMed ID: 23708048
[TBL] [Abstract][Full Text] [Related]
9. Glioma stem cells are more aggressive in recurrent tumors with malignant progression than in the primary tumor, and both can be maintained long-term in vitro.
Huang Q; Zhang QB; Dong J; Wu YY; Shen YT; Zhao YD; Zhu YD; Diao Y; Wang AD; Lan Q
BMC Cancer; 2008 Oct; 8():304. PubMed ID: 18940013
[TBL] [Abstract][Full Text] [Related]
10. [Chemoresistance of CD133(+) tumor stem cells from human brain glioma].
Bi CL; Fang JS; Chen FH; Wang YJ; Wu J
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2007 Aug; 32(4):568-73. PubMed ID: 17767043
[TBL] [Abstract][Full Text] [Related]
11. Glioma cell populations grouped by different cell type markers drive brain tumor growth.
Prestegarden L; Svendsen A; Wang J; Sleire L; Skaftnesmo KO; Bjerkvig R; Yan T; Askland L; Persson A; Sakariassen PØ; Enger PØ
Cancer Res; 2010 Jun; 70(11):4274-9. PubMed ID: 20460538
[TBL] [Abstract][Full Text] [Related]
12. Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.
Chiou SH; Yu CC; Huang CY; Lin SC; Liu CJ; Tsai TH; Chou SH; Chien CS; Ku HH; Lo JF
Clin Cancer Res; 2008 Jul; 14(13):4085-95. PubMed ID: 18593985
[TBL] [Abstract][Full Text] [Related]
13. CD133 Expression Is Not Synonymous to Immunoreactivity for AC133 and Fluctuates throughout the Cell Cycle in Glioma Stem-Like Cells.
Barrantes-Freer A; Renovanz M; Eich M; Braukmann A; Sprang B; Spirin P; Pardo LA; Giese A; Kim EL
PLoS One; 2015; 10(6):e0130519. PubMed ID: 26086074
[TBL] [Abstract][Full Text] [Related]
14. [Activation of CXCR4 in human glioma stem cells promotes tumor angiogenesis].
Ping YF; Yao XH; Bian XW; Chen JH; Zhang R; Yi L; Zhou ZH
Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):179-83. PubMed ID: 17535685
[TBL] [Abstract][Full Text] [Related]
15. Identification of A2B5+CD133- tumor-initiating cells in adult human gliomas.
Ogden AT; Waziri AE; Lochhead RA; Fusco D; Lopez K; Ellis JA; Kang J; Assanah M; McKhann GM; Sisti MB; McCormick PC; Canoll P; Bruce JN
Neurosurgery; 2008 Feb; 62(2):505-14; discussion 514-5. PubMed ID: 18382330
[TBL] [Abstract][Full Text] [Related]
16. The VHL tumor suppressor protein regulates tumorigenicity of U87-derived glioma stem-like cells by inhibiting the JAK/STAT signaling pathway.
Kanno H; Sato H; Yokoyama TA; Yoshizumi T; Yamada S
Int J Oncol; 2013 Mar; 42(3):881-6. PubMed ID: 23338840
[TBL] [Abstract][Full Text] [Related]
17. Epigenetic regulation of CD133 and tumorigenicity of CD133+ ovarian cancer cells.
Baba T; Convery PA; Matsumura N; Whitaker RS; Kondoh E; Perry T; Huang Z; Bentley RC; Mori S; Fujii S; Marks JR; Berchuck A; Murphy SK
Oncogene; 2009 Jan; 28(2):209-18. PubMed ID: 18836486
[TBL] [Abstract][Full Text] [Related]
18. Coencapsulation of epirubicin and metformin in PEGylated liposomes inhibits the recurrence of murine sarcoma S180 existing CD133+ cancer stem-like cells.
Yang Q; Zhang T; Wang C; Jiao J; Li J; Deng Y
Eur J Pharm Biopharm; 2014 Nov; 88(3):737-45. PubMed ID: 25460146
[TBL] [Abstract][Full Text] [Related]
19. Cancer stem-like cell behavior in anaplastic thyroid cancer: A challenging dilemma.
Haghpanah V; Fallah P; Naderi M; Tavakoli R; Soleimani M; Larijani B
Life Sci; 2016 Feb; 146():34-9. PubMed ID: 26772823
[TBL] [Abstract][Full Text] [Related]
20. Expansion of CD133-positive glioma cells in recurrent de novo glioblastomas after radiotherapy and chemotherapy.
Tamura K; Aoyagi M; Ando N; Ogishima T; Wakimoto H; Yamamoto M; Ohno K
J Neurosurg; 2013 Nov; 119(5):1145-55. PubMed ID: 23991844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
